Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH – Get Free Report)’s share price fell 0.7% on Wednesday . The company traded as low as $0.61 and last traded at $0.61. 40,294 shares were traded ...

Kumaraguru Raja, an analyst from Brookline Capital Markets, has initiated a new Buy rating on Quince Therapeutics (QNCX).Pick the best stocks ...

A DAD was given years to live and faces a painful death after noticing his fingers were “paper white” after spending time in ...

ATRN-119 is a small molecule commercialized by Aprea Therapeutics, with a leading Phase II program in Ovarian Cancer;Cervical Cancer;Endometrial Cancer;Fallopian Tube Cancer.

The drug candidate is administered through oral route in the form of film coated tablet and gelatin coated capsule. It targets ataxia telangiectasia and rad3 related (ATR) kinase. It was also under ...

Growth of the global radiodermatitis market is majorly driven by increase in prevalence of cancer and rise in adoption of radiotherapy for treatment globally. Furthermore, increase in geriatric ...

NI parents reflect on lack of services for disabled young people and call for more investment in face-to-face services to mark International Day. | UTV News ...

today announced that a study in health economics and outcomes research focused on the cost and clinical burden in people suffering with hereditary hemorrhagic telangiectasia (HHT) will be presented at ...

TEL AVIV, Israel, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for ...

Ataxia-Telangiectasia (A-T) is a rare, autosomal recessive disorder characterized by progressive cerebellar ataxia, oculocutaneous telangiectasia, immunodeficiency, and increased cancer risk.